Back to search results

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioblastoma Multiforme (GBM) · Glioblastoma · Glioma of Brain · Glioblastoma, Adult · Brain Tumor · Brain Tumor, Primary · Brain Tumor Adult · Cancer · Brain Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Lenox Hill Brain Tumor Center, New York, New York, United States

    Contact: Study coordinator (Tamika Wong, MPH) · twong4@northwell.edu · 212-434-4836
    Contact: Principal Investigator (John Boockvar, MD)
    David Langer, MD (Sub-investigator)
    Anuj Goenka, MD (Sub-investigator)
    Christopher Filippi, MD (Sub-investigator)
    Lalitha Anand, MD (Sub-investigator)
    Sherese Fralin, NP (Sub-investigator)
    Ashley Ray, NP (Sub-investigator)
    Tamika Wong, MPH (Sub-investigator)
Study leads

  • John Boockvar, MD

    Principal Investigator

    Lenox Hill Hospital-Northwell Health

View source on ClinicalTrials.gov(opens in a new tab)